ProfileGDS5678 / 1452996_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 32% 44% 45% 46% 44% 43% 42% 55% 44% 45% 44% 45% 42% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7521732
GSM967853U87-EV human glioblastoma xenograft - Control 23.0299744
GSM967854U87-EV human glioblastoma xenograft - Control 33.04445
GSM967855U87-EV human glioblastoma xenograft - Control 43.0148746
GSM967856U87-EV human glioblastoma xenograft - Control 52.9739944
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0776243
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0374242
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3711455
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9974144
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0400145
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0248344
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0267545
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9841342
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0859846